How long does it take to lower cholesterol
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
How Long Does It Take to Lower Cholesterol?
Immediate Effects of Dietary Changes on Cholesterol Levels
Rapid Response to Lipid-Lowering Diets
Research indicates that adopting a lipid-lowering diet can lead to a significant reduction in plasma cholesterol levels within a very short period. A study found that participants who switched from a diet high in saturated fats to one rich in polyunsaturated fats experienced a notable decrease in plasma total cholesterol within just two days. By the fifth day, 59% of the maximum reduction was achieved, and the full effect was observed within two weeks.
Long-Term Efficacy of Dietary Interventions
While short-term dietary changes can quickly lower cholesterol, maintaining these changes is crucial for long-term benefits. A review of multiple trials showed that more intensive diets could reduce serum cholesterol by 6.5-15.5% over periods ranging from one to five years. However, less rigorous diets, such as the step 1 diet, resulted in minimal reductions of 0-4% over six months to six years.
Pharmacological Interventions for Cholesterol Reduction
Statins and Rapid Cholesterol Reduction
Statins are a common pharmacological intervention for lowering cholesterol. Studies have shown that statins can significantly reduce LDL cholesterol levels within a short period. For instance, simvastatin was found to lower LDL cholesterol by 56 mg/dL within seven days, with further reductions observed by day 14. Another study demonstrated that simvastatin could reduce total cholesterol and LDL cholesterol by 19% and 29%, respectively, within three months, with sustained effects over one year.
Long-Term Benefits of Statins
Long-term use of statins has been shown to provide substantial benefits. A meta-analysis of 14 randomized trials involving over 90,000 participants found that statin therapy could reduce the incidence of major vascular events by about one fifth per mmol/L reduction in LDL cholesterol over five years. These benefits were significant within the first year and increased in subsequent years.
Novel Therapies and Long-Term Efficacy
Inclisiran and Sustained LDL-C Reduction
Inclisiran, a small interfering RNA, offers a novel approach to LDL-C reduction with the convenience of infrequent dosing. A study found that a single dose of inclisiran could reduce LDL-C levels by 29.5-38.7% over one year, while two doses resulted in reductions of 29.9-46.4%. The highest proportion of responders and the greatest mean reduction were observed with the two-dose regimen.
Alirocumab for High-Risk Patients
Alirocumab, a monoclonal antibody that inhibits PCSK9, has also shown promise in reducing LDL cholesterol levels. In a study involving high-risk patients, alirocumab reduced LDL cholesterol by 62% over 24 weeks, with consistent effects over 78 weeks. Additionally, a post hoc analysis suggested a reduction in the rate of major adverse cardiovascular events.
Conclusion
Lowering cholesterol can be achieved relatively quickly through dietary changes, with significant reductions observed within two weeks. Pharmacological interventions, particularly statins, can also rapidly reduce cholesterol levels, with long-term use providing substantial cardiovascular benefits. Novel therapies like inclisiran and alirocumab offer promising alternatives with sustained efficacy and the convenience of less frequent dosing. For optimal results, a combination of dietary modifications and pharmacological treatments may be necessary, especially for individuals at high risk of cardiovascular events.
Sources and full results
Most relevant research papers on this topic